NZ191837A - Antigen or antibody-containing microparticles - Google Patents

Antigen or antibody-containing microparticles

Info

Publication number
NZ191837A
NZ191837A NZ191837A NZ19183779A NZ191837A NZ 191837 A NZ191837 A NZ 191837A NZ 191837 A NZ191837 A NZ 191837A NZ 19183779 A NZ19183779 A NZ 19183779A NZ 191837 A NZ191837 A NZ 191837A
Authority
NZ
New Zealand
Prior art keywords
microparticles
antigen
antibody
hormone
matrix material
Prior art date
Application number
NZ191837A
Other languages
English (en)
Inventor
L R Beck
D R Cowsar
C E Flowers
A C Tanquary
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of NZ191837A publication Critical patent/NZ191837A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NZ191837A 1978-10-17 1979-10-12 Antigen or antibody-containing microparticles NZ191837A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95210978A 1978-10-17 1978-10-17
US96738078A 1978-12-07 1978-12-07

Publications (1)

Publication Number Publication Date
NZ191837A true NZ191837A (en) 1984-07-31

Family

ID=27130325

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ191837A NZ191837A (en) 1978-10-17 1979-10-12 Antigen or antibody-containing microparticles

Country Status (13)

Country Link
AU (1) AU528186B2 (it)
CA (1) CA1143289A (it)
CH (1) CH645545A5 (it)
DE (1) DE2940146A1 (it)
FR (1) FR2439014A1 (it)
GB (1) GB2034182B (it)
IE (1) IE48851B1 (it)
IL (1) IL58471A (it)
IT (1) IT1124572B (it)
NL (1) NL184723C (it)
NZ (1) NZ191837A (it)
PH (1) PH25638A (it)
SE (1) SE7908520L (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US5366734A (en) * 1981-02-16 1994-11-22 Zeneca Limited Continuous release pharmaceutical compositions
CH661206A5 (fr) * 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US5000886A (en) * 1987-05-26 1991-03-19 American Cyanamid Company Silicone-hardened pharmaceutical microcapsules and process of making the same
EP0300102B1 (en) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Improved method of obtaining immune regulatory factors by mammal immunization
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
FR2620335A1 (fr) * 1987-09-15 1989-03-17 Berdal Pascal Presentation pharmaceutique potentialisant l'effet cytotrophique des serums et/ou des anticorps antitissus animaux et/ou humains
US5084277A (en) * 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
EP0778768B1 (en) 1995-06-09 2004-05-26 Euroceltique S.A. Formulations and methods for providing prolonged local anesthesia
WO1997049391A1 (en) 1996-06-24 1997-12-31 Euro-Celtique, S.A. Methods for providing safe local anesthesia
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
IL129951A0 (en) 1997-07-02 2000-02-29 Euro Celtique Sa Prolonged anesthesia in joints and body spaces

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3594468A (en) * 1969-04-01 1971-07-20 Vincent R Saurino Germicidal compositions
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3875300A (en) * 1972-12-18 1975-04-01 Ortho Pharma Corp Composition for sustained release of a medicament and method of using same
AU513400B2 (en) * 1976-03-04 1980-11-27 Commonwealth Serum Laboratories Commission Biodegradable, sustained release composition

Also Published As

Publication number Publication date
DE2940146A1 (de) 1980-04-30
GB2034182B (en) 1983-07-27
IT1124572B (it) 1986-05-07
SE7908520L (sv) 1980-04-18
CH645545A5 (de) 1984-10-15
IL58471A0 (en) 1980-01-31
IT7926288A0 (it) 1979-10-05
AU528186B2 (en) 1983-04-21
FR2439014B1 (it) 1983-12-09
IE48851B1 (en) 1985-05-29
GB2034182A (en) 1980-06-04
NL7907432A (nl) 1980-04-21
DE2940146C2 (it) 1991-12-05
NL184723B (nl) 1989-05-16
IE791966L (en) 1980-04-17
IL58471A (en) 1983-05-15
AU5169679A (en) 1980-04-24
FR2439014A1 (fr) 1980-05-16
NL184723C (nl) 1989-10-16
CA1143289A (en) 1983-03-22
PH25638A (en) 1991-08-31

Similar Documents

Publication Publication Date Title
US4756907A (en) Active/passive immunization of the internal female reproductive organs
US4732763A (en) Active/passive immunization of the internal female reproductive organs
US4585651A (en) Active/passive immunization of the internal female reproductive organs
CA1143289A (en) Microparticle drug delivery system
Woolfson et al. Drug delivery by the intravaginal route
KR101730517B1 (ko) 프로게스테론 함유 단일형 질내 링 및 그의 제조방법과 용도
US6028057A (en) Regulation of estrus and ovulation in gilts
Benagiano et al. Contraception today
ES2337129T3 (es) Sistema de administracion de medicamento comprendiendo un estrogeno tetrahidroxilado para el uso en la anticoncepcion hormonal.
SG184111A1 (en) Parenteral pharmaceutical form which releases aromatse inhibitor and gestagens, for the treatment of endometriosis
US11793669B2 (en) Combination therapy intravaginal rings
Lee et al. Drug delivery: Vaginal route
WO2012121767A1 (en) Treatment of uterine fibroids by intravaginal administration of a low dose of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent
Beck et al. Controlled-release delivery systems for hormones: a review of their properties and current therapeutic use
Beck et al. Long-acting injectable microsphere formulation for the parenteral administration of levonorgestrel
US20190328657A1 (en) Hormonal contraception using a vaginal ring which releases estriol
JPH024576B2 (it)
CA2517778A1 (en) Extended transdermal contraceptive regimens
Malcolm et al. 21 Vagina and Uterus as Drug-Absorbing Organs
Nayak et al. Novel approaches in vaginal drug delivery systems for local and systemic treatments
JP2001505589A (ja) 雄の避妊薬としてのアンドロゲン及び非避妊アンドロゲン補充体
Machado et al. Efficacy of norethindrone acetate and norgestomet implants in suppressing estrus in female beef cattle
Lipp Novel drug delivery systems for steroidal hormones
US20240115490A1 (en) Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof
US4264578A (en) Contraceptive methods and compositions